These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8887134)

  • 1. Bone mass in children with congenital hypothyroidism treated with thyroxine since birth.
    Kooh SW; Brnjac L; Ehrlich RM; Qureshi R; Krishnan S
    J Pediatr Endocrinol Metab; 1996; 9(1):59-62. PubMed ID: 8887134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral density and metabolism in children with congenital hypothyroidism after prolonged L-thyroxine therapy.
    Leger J; Ruiz JC; Guibourdenche J; Kindermans C; Garabedian M; Czernichow P
    Acta Paediatr; 1997 Jul; 86(7):704-10. PubMed ID: 9240877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-term L-thyroxine treatment on bone mineral density in young adults with congenital hypothyroidism.
    Salerno M; Lettiero T; Esposito-del Puente A; Esposito V; Capalbo D; Carpinelli A; Padula S; del Puente A
    Eur J Endocrinol; 2004 Dec; 151(6):689-94. PubMed ID: 15588234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of replacement doses of thyroxine on bone mineral density.
    Hanna FW; Pettit RJ; Ammari F; Evans WD; Sandeman D; Lazarus JH
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):229-34. PubMed ID: 9579237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone density is not reduced during the short-term administration of levothyroxine to postmenopausal women with subclinical hypothyroidism: a randomized, prospective study.
    Ross DS
    Am J Med; 1993 Oct; 95(4):385-8. PubMed ID: 8213870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism.
    Salerno M; Militerni R; Bravaccio C; Micillo M; Capalbo D; Di MS; Tenore A
    Thyroid; 2002 Jan; 12(1):45-52. PubMed ID: 11838730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine.
    Stall GM; Harris S; Sokoll LJ; Dawson-Hughes B
    Ann Intern Med; 1990 Aug; 113(4):265-9. PubMed ID: 2375563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density in adolescent females treated with L-thyroxine: a longitudinal study.
    Saggese G; Bertelloni S; Baroncelli GI; Costa S; Ceccarelli C
    Eur J Pediatr; 1996 Jun; 155(6):452-7. PubMed ID: 8789760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral metabolism and thyroid replacement therapy in congenital hypothyroid infants and young children.
    Weber G; Mora S; Bellini A; Bosco M; Prinster C; Siragusa V; di Natale B; Chiumello G
    J Endocrinol Invest; 1995 Apr; 18(4):277-82. PubMed ID: 7560809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mass, bone turnover and body composition in former hypothyroid patients receiving replacement therapy.
    Langdahl BL; Loft AG; Eriksen EF; Mosekilde L; Charles P
    Eur J Endocrinol; 1996 Jun; 134(6):702-9. PubMed ID: 8766939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term thyroxine treatment and bone mineral density.
    Franklyn JA; Betteridge J; Daykin J; Holder R; Oates GD; Parle JV; Lilley J; Heath DA; Sheppard MC
    Lancet; 1992 Jul; 340(8810):9-13. PubMed ID: 1351654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prepubertal and pubertal growth, timing and duration of puberty and attained adult height in patients with congenital hypothyroidism (CH) detected by the neonatal screening programme for CH--a longitudinal study.
    Dickerman Z; De Vries L
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):649-54. PubMed ID: 9497870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linear growth in early treated children with congenital hypothyroidism.
    Heyerdahl S; Ilicki A; Karlberg J; Kase BF; Larsson A
    Acta Paediatr; 1997 May; 86(5):479-83. PubMed ID: 9183486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis.
    Franklyn J; Betteridge J; Holder R; Daykin J; Lilley J; Sheppard M
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):425-32. PubMed ID: 7955453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral density in patients receiving suppressive doses of thyroxine for thyroid carcinoma.
    Florkowski CM; Brownlie BE; Elliot JR; Ayling EM; Turner JG
    N Z Med J; 1993 Oct; 106(966):443-4. PubMed ID: 8233173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital hypothyroidism: no adverse effects of high dose thyroxine treatment on adult memory, attention, and behaviour.
    Oerbeck B; Sundet K; Kase BF; Heyerdahl S
    Arch Dis Child; 2005 Feb; 90(2):132-7. PubMed ID: 15665163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Children with congenital hypothyroidism and their siblings: do they really differ?
    Rovet JF
    Pediatrics; 2005 Jan; 115(1):e52-7. PubMed ID: 15629966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density and metabolism in premenopausal women taking L-thyroxine replacement therapy.
    Garton M; Reid I; Loveridge N; Robins S; Murchison L; Beckett G; Reid D
    Clin Endocrinol (Oxf); 1994 Dec; 41(6):747-55. PubMed ID: 7889610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative computed tomography measurements of bone mineral density in prepubertal children with congenital hypothyroidism treated with L-thyroxine.
    Pitukcheewanont P; Safani D; Gilsanz V; Klein M; Chongpison Y; Costin G
    J Pediatr Endocrinol Metab; 2004 Jun; 17(6):889-93. PubMed ID: 15270407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of height and bone age in primary congenital hypothyroidism.
    Casado de Frías E; Ruibal JL; Reverte F; Bueno G
    Clin Pediatr (Phila); 1993 Jul; 32(7):426-32. PubMed ID: 8365078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.